Editor’s note: The GeekWire Awards event has been postponed to May 19.
Technology is increasingly influencing the science of health, and the delivery of health care. Scientists and entrepreneurs from the Seattle area are finding new ways to address some of the biggest challenges in health by leveraging some of the region’s inherent strengths.
This confluence of trends is especially evident this year in the Health Innovation of the Year category for the GeekWire Awards. This category recognizes pioneering health, life science, biotechnology and medical breakthroughs that promise to meaningfully improve lives, either directly or by improving the health care system.
Today we’re recognizing the five finalists in this category for 2020: Athira Pharma, Blaze Bioscience, the Fred Hutchinson Cancer Research Center, Sana Biotechnology and Sound Life Sciences. Learn more about each finalist and cast your ballot below.
Community voting is now under way across across 13 GeekWire Awards categories. These community votes will be combined with feedback from more than 20 judges to determine the winner in each category. We’ll announce the results live on stage May 19 at the GeekWire Awards — presented by Wave Business — in front of more than 800 geeks at the Museum of Pop Culture in Seattle. You can register for tickets on the event site or below.
Virtual primary care startup 98point6 took home the prize in the Health Innovation of the Year category last year.Create your own user feedback survey
- Athira Pharma: This biotech startup is developing new drugs that could halt or reverse the nerve damage that causes Alzheimer’s disease and other illnesses, including Parkinson’s and ALS. The company in December presented what it described as positive initial results from a clinical trial that included patients with Alzheimer’s disease.
- Blaze Bioscience: Blaze Bioscience is using a protein borrowed from scorpion venom to make cancerous tumors glow. Blaze’s “tumor paint” technology, called BLZ-100 or tozuleristide, helps surgeons spot and remove solid tumor cells in patients. The company passed its first clinical trial last year.
- Fred Hutchinson Cancer Research Center: Fred Hutch researchers have demonstrated the effectiveness of a new method for getting immune cells to fight solid tumors — by spreading them like jam onto ultra-thin sheets of metal mesh, and then laying the mesh onto the tumors.
- Sana Biotechnology: Former Juno Therapeutics executives Hans Bishop and Steve Harr launched Sana Biotechnology, a startup focused on cell therapy, gene therapy and gene editing. The company plans to create medicines across a range of areas, including modifying cells both inside and outside the body as well as immunological treatments to improve the reception of donor cells.
- Sound Life Sciences: An app that uses sonar to detect opioid overdoses made the leap from research to startup with the formation of a new company called Sound Life Sciences. The Second Chance app is the product of University of Washington researchers who set out to turn a smartphone’s microphone and speaker into a lifesaving device.